Skip to main content
    W

    Whitehawk Therapeutics, Inc. (WHWK)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.04
    +0.07 (+2.36%)

    Market Cap: $169.32M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    68%(17/25)
    Avg Surprise
    -14.16%
    Streak
    3 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.24
    Range$-0.27 - $-0.21
    4 analysts
    EPS Revisions
    2
    0
    7d
    2
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.29+17.2%
    60d ago$-0.27+11.2%
    30d ago$-0.25+3.7%
    7d ago$-0.25+3.7%
    Current$-0.24
    Revenue Consensus
    $0
    Range$0 - $0
    9 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.15
    Range$-0.21 - $-0.08
    3 analysts
    Revenue Consensus
    $262500
    Range$262500 - $262500
    9 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.15---
    Sep 26EST
    		-$-0.24---
    Jun 26
    Reported Aug 6
    		$-0.20$-0.30+33.33%Beat+73.7%
    Mar 26
    Reported May 7
    		$-0.32$-0.33+3.03%Beat+11.1%
    Dec 25
    Reported Mar 12
    		$-0.34N/A+50.74%Beat+49.3%
    Sep 25
    Reported Nov 6
    		$-0.25$-0.22-13.64%Miss+32.4%
    Jun 25
    Reported Aug 7
    		$-0.76$0.49-255.10%Miss-40.7%
    Mar 25
    Reported May 8
    		$-0.36$-0.23-56.52%Miss+47.1%
    Dec 24
    Reported Mar 18
    		$-0.67$-0.21-219.05%Miss-11.7%
    Sep 24
    Reported Nov 6
    		$-0.37$-0.47+21.28%Beat+38.3%
    Jun 24
    Reported Aug 7
    		$-0.54$-0.64+15.63%Beat+19.4%
    Mar 24
    Reported May 8
    		$-0.68$-0.62-9.68%Miss-19.3%
    Dec 23
    Reported Mar 13
    		$-0.60$-0.65+7.69%Beat-25.0%
    Sep 23
    Reported Nov 8
    		$-0.60$-0.73+17.81%Beat+11.8%
    Jun 23
    Reported Aug 9
    		$-0.67$-0.60-11.67%Miss+2.9%
    Mar 23
    Reported May 10
    		$-0.57$-0.57+0.00%Beat+13.6%
    Dec 22
    Reported Mar 29
    		$-0.48$-0.72+33.33%Beat+37.7%
    Sep 22
    Reported Nov 9
    		$-0.68$-0.75+9.33%Beat+52.1%
    Jun 22
    Reported Aug 10
    		$-0.69$-0.73+5.48%Beat+48.9%
    Mar 22
    Reported May 12
    		$-0.66$-0.68+2.94%Beat-633.3%
    Dec 21
    Reported Mar 17
    		$-0.77$-0.77+0.00%Beat-670.0%
    Sep 21
    Reported Nov 10
    		$-1.42$-0.73-94.52%Miss-1083.3%
    Jun 21
    Reported Aug 11
    		$-1.35N/A+77.50%Beat-687.0%
    Mar 21
    Reported May 17
    		$-0.09$-0.09+0.00%Beat+93.8%
    Dec 20
    Reported Mar 11
    		$-0.10$-0.14+28.57%Beat+93.9%
    Sep 20
    Reported Nov 10
    		$-0.12$-0.14+14.29%Beat+93.0%
    Jun 20
    Reported Aug 12
    		$0.23$0.27-14.81%Miss+110.9%
    Mar 20
    Reported May 7
    		$-1.45N/AN/ABeat+53.9%
    Dec 19
    Reported Mar 16
    		$-1.64N/AN/ABeat+47.8%
    Sep 19
    Reported Nov 7
    		$-1.72N/AN/ABeat-140.7%
    Jun 19
    Reported Aug 8
    		$-2.10N/AN/ABeat+36.1%
    Mar 19
    Reported May 9
    		$-3.14N/AN/ABeat+23.8%
    Dec 18
    Reported Mar 5
    		$-3.15N/AN/ABeat+9.2%
    Sep 18
    Reported Nov 7
    		$4.22N/AN/ABeat+263.1%
    Jun 18
    Reported Aug 14
    		$-3.29N/AN/ABeat-
    Mar 18
    Reported May 15
    		$-4.12N/AN/ABeat-
    Dec 17
    Reported Mar 13
    		$-3.47N/AN/ABeat-
    Sep 17
    Reported Nov 29
    		$-2.59N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-2.74EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-45.00%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio17.38xQuick Ratio17.38x
    Trading Statistics
    Beta0.91Avg Volume371.42K
    52-Week High$5.5052-Week Low$1.97

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.38
    SMA 20$3.63
    SMA 50$4.19
    SMA 200$3.80
    EMA 10$3.33
    EMA 20$3.57
    EMA 50$3.91
    EMA 200$3.71

    MACD

    Line: -0.29Signal: -0.24Hist: -0.06

    ADX

    ADX: 36.1+DI: 8.5-DI: 35.8

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down96.0
    PSAR$3.54

    Bollinger Bands

    Upper Band$4.30
    Lower Band$2.96
    %B Position3699%(Upper)
    Band Width0.06

    RSI (14-Day)

    Oversold
    24.5

    Momentum Oscillators

    Stoch %K4.9
    Stoch %D6.4
    Williams %R-90.2
    ROC (10d)-19.1%
    Momentum-0.72
    CCI (20d)-159.4
    MFI (14d)24.2

    Volatility Measures

    ATR (14d)$0.19(6.4%)
    StdDev (20d)0.34
    Hist Vol52.5%(High)

    Volume Flow

    VWAP$3.03
    OBV106.1M
    AD Line-73.3M
    CMF (20d)-0.144

    Volume Metrics

    Avg Vol (20d)393.5K
    Vol Ratio0.9x
    VWMA (20d)$3.70

    Pivot Points

    R3$3.23
    R2$3.17
    R1$3.07
    Pivot Point$3.01
    S1$2.91
    S2$2.84
    S3$2.74

    Advanced Oscillators

    TSI-45.38
    Ultimate Osc32.4
    KST-209.53

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$7.14M$7.24M$7.21M$6.18M$5.35M$6.33M$5.96M
    Cost of Revenue$0$0$1,000$0$0$760,000$790,000$804,000$778,000$652,000$927,000$697,000
    Gross Profit$0$0$-1,000$0$0$6.38M$6.45M$6.41M$5.40M$4.70M$5.40M$5.26M
    Operating Expenses$18.11M$23.52M$24.89M$19.55M$54.75M$21.60M$25.40M$19.82M$20.98M$24.21M$23.11M$23.11M
    R&D$12.89M$17.23M$19.02M$14.35M$48.81M$8.79M$14.35M$10.00M$13.09M$13.59M$12.77M$11.89M
    SG&A$5.22M$6.29M$5.87M$5.20M$5.94M$12.81M$11.05M$7.19M$7.89M$10.62M$10.35M$11.22M
    Operating Income$-18,109,000$-23,522,000$-24,887,000$-19,546,000$-54,749,000$-15,218,000$-18,949,000$-13,413,000$-15,584,000$-19,512,000$-17,714,000$-17,849,000
    Interest Income$1.48M$1.33M$1.61M$1.85M$1.98M$791,000$676,000$906,000$1.06M$1.28M$1.50M$1.60M
    Interest Expense$0$0$0$0$0$0$0$38,000$58,000$58,000$57,000$58,000
    Income Before Tax$-16,640,000$-22,194,000$-23,251,000$-17,746,000$-52,615,000$73.02M$-18,273,000$-12,546,000$-14,583,000$-18,289,000$-16,269,000$-16,302,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-16,640,000$-22,194,000$-23,251,000$-17,746,000$-52,615,000$73.02M$-18,273,000$-12,546,000$-14,583,000$-18,289,000$-16,269,000$-16,302,000
    EBITDA$-18,473,000$-23,868,000$-25,692,000$-20,308,000$-54,576,000$72.30M$-19,085,000$-13,676,000$-15,924,000$-19,885,000$-18,154,000$-18,393,000
    EBIT$-18,115,000$-23,522,000$-24,862,000$-19,596,000$-54,594,000$72.22M$-18,949,000$-13,414,000$-15,586,000$-19,513,000$-17,712,000$-17,849,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about WHWK

    News

    Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Stock Has Consensus Target Price of $8.33 According to Brokerages

    Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) has received a "Moderate Buy" consensus rating from eight brokerages, with an average 12-month price target of $8.33. Institutional investors hold 52.08% of the stock...

    MarketBeat•10/8/26•Neutral

    Stifel Maintains Whitehawk Therapeutics(WHWK.US) With Buy Rating, Maintains Target Price $9

    Stifel has reiterated its Buy rating for Whitehawk Therapeutics (WHWK.US) and maintained its price target at $9. This indicates continued confidence from the analyst firm in the company's prospects.

    Moomoo•10/1/26•Bullish

    Stifel Initiates Whitehawk Therapeutics(WHWK.US) With Buy Rating, Announces Target Price $9

    Stifel has initiated coverage on Whitehawk Therapeutics (WHWK.US) with a Buy rating. The firm has set a target price of $9 for the company's stock. This new analyst coverage suggests a positive outlook for Whitehawk...

    Moomoo•10/1/26•Bullish

    Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026

    Whitehawk Therapeutics presented two real-world analyses at the IGCS Annual Global Meeting 2026, demonstrating MUC16 as a durable therapeutic target and potential prognostic biomarker in ovarian cancer. The data show...

    PR Newswire•10/1/26•Bullish

    Stifel Initiates Whitehawk Therapeutics at Buy With $9 Price Target

    Stifel has initiated coverage of Whitehawk Therapeutics (WHWK) with a "Buy" rating and a price target of $9.00. This new rating contributes to an average analyst rating of "overweight" for Whitehawk Therapeutics...

    Yahoo Finance•10/1/26•Bullish

    WHWK Valuation and Fair Value

    P/E
    -2.7x
    Forward P/E
    2.7x
    P/B
    1.4x
    See GNG's fair value

    WHWK Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -45.0%

    WHWK Competitors

    CompanyTicker
    Oramed Pharmaceuticals IncORMP
    Precision BioSciences IncDTIL
    Sutro BiopharmaSTRO
    Coherus BioSciences IncCHRS
    Invivyd Inc.IVVD
    Innate PharmaIPHA
    Sionna Therapeutics, Inc. Common StockSION
    PepGen LtdPEPG

    Sector: Healthcare

    WHWK Analyst Ratings

    Consensus
    Buy
    Analysts
    8
    Strong Buy
    1
    Buy
    4
    Hold
    3
    Sell
    0
    Strong Sell
    0

    WHWK Bull Case vs Bear Case

    Bull case

    • 62.5% of WHWK's analyst ratings are Buy or Strong Buy.

    Bear case

    • WHWK's quarterly revenue changed -100.0% year over year.

    WHWK Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -54.5%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.24
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    2 up, 0 down

    Frequently Asked Questions About WHWK

    Does WHWK pay dividends?

    Whitehawk Therapeutics, Inc. (WHWK) does not currently pay a regular dividend.

    What is WHWK's market cap?

    Whitehawk Therapeutics, Inc. (WHWK) has a market capitalization of $169.32M with a current stock price of $3.04.

    Related stocks

    Sector: Healthcare

    All stocks starting with W

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In